KBH vs. MDGL
Compare and contrast key facts about KB Home (KBH) and Madrigal Pharmaceuticals, Inc. (MDGL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KBH or MDGL.
Correlation
The correlation between KBH and MDGL is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
KBH vs. MDGL - Performance Comparison
Loading data...
Key characteristics
KBH:
-0.71
MDGL:
0.63
KBH:
-0.67
MDGL:
1.43
KBH:
0.93
MDGL:
1.17
KBH:
-0.49
MDGL:
0.75
KBH:
-0.99
MDGL:
2.80
KBH:
21.48%
MDGL:
13.62%
KBH:
36.90%
MDGL:
60.05%
KBH:
-92.78%
MDGL:
-98.40%
KBH:
-38.61%
MDGL:
-28.80%
Fundamentals
KBH:
$3.87B
MDGL:
$6.28B
KBH:
$8.18
MDGL:
-$17.85
KBH:
0.63
MDGL:
0.00
KBH:
0.56
MDGL:
19.79
KBH:
0.98
MDGL:
8.84
KBH:
$6.85B
MDGL:
$317.38M
KBH:
$1.44B
MDGL:
$306.81M
KBH:
$798.36M
MDGL:
-$376.15M
Returns By Period
In the year-to-date period, KBH achieves a -16.54% return, which is significantly lower than MDGL's -5.43% return. Over the past 10 years, KBH has outperformed MDGL with an annualized return of 15.26%, while MDGL has yielded a comparatively lower 13.58% annualized return.
KBH
-16.54%
7.06%
-30.16%
-25.74%
18.98%
15.26%
MDGL
-5.43%
-9.12%
-3.58%
37.83%
19.84%
13.58%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KBH vs. MDGL — Risk-Adjusted Performance Rank
KBH
MDGL
KBH vs. MDGL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for KB Home (KBH) and Madrigal Pharmaceuticals, Inc. (MDGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
KBH vs. MDGL - Dividend Comparison
KBH's dividend yield for the trailing twelve months is around 1.84%, while MDGL has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KBH KB Home | 1.84% | 1.45% | 1.12% | 1.88% | 1.34% | 1.25% | 0.67% | 0.52% | 0.31% | 0.63% | 0.81% | 0.60% |
MDGL Madrigal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
KBH vs. MDGL - Drawdown Comparison
The maximum KBH drawdown since its inception was -92.78%, smaller than the maximum MDGL drawdown of -98.40%. Use the drawdown chart below to compare losses from any high point for KBH and MDGL. For additional features, visit the drawdowns tool.
Loading data...
Volatility
KBH vs. MDGL - Volatility Comparison
The current volatility for KB Home (KBH) is 10.00%, while Madrigal Pharmaceuticals, Inc. (MDGL) has a volatility of 12.34%. This indicates that KBH experiences smaller price fluctuations and is considered to be less risky than MDGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
KBH vs. MDGL - Financials Comparison
This section allows you to compare key financial metrics between KB Home and Madrigal Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KBH vs. MDGL - Profitability Comparison
KBH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, KB Home reported a gross profit of 282.82M and revenue of 1.39B. Therefore, the gross margin over that period was 20.3%.
MDGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Madrigal Pharmaceuticals, Inc. reported a gross profit of 132.74M and revenue of 137.25M. Therefore, the gross margin over that period was 96.7%.
KBH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, KB Home reported an operating income of 127.34M and revenue of 1.39B, resulting in an operating margin of 9.2%.
MDGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Madrigal Pharmaceuticals, Inc. reported an operating income of -79.31M and revenue of 137.25M, resulting in an operating margin of -57.8%.
KBH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, KB Home reported a net income of 109.56M and revenue of 1.39B, resulting in a net margin of 7.9%.
MDGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Madrigal Pharmaceuticals, Inc. reported a net income of -73.24M and revenue of 137.25M, resulting in a net margin of -53.4%.